[
  {
    "ts": null,
    "headline": "Pulling Back for a Fresh Look at This Recent Pullback",
    "summary": "Fed members are openly having second thoughts about further cuts to interest rates, especially with no new data on the jobs or inflation front.",
    "url": "https://finnhub.io/api/news?id=606c43fa5e1d9e95085ddfb64965b5b423d908f65130b26ef0766644b7dd0b87",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763075100,
      "headline": "Pulling Back for a Fresh Look at This Recent Pullback",
      "id": 137476948,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Fed members are openly having second thoughts about further cuts to interest rates, especially with no new data on the jobs or inflation front.",
      "url": "https://finnhub.io/api/news?id=606c43fa5e1d9e95085ddfb64965b5b423d908f65130b26ef0766644b7dd0b87"
    }
  },
  {
    "ts": null,
    "headline": "Tracking Ken Fisher's Fisher Asset Management Portfolio - Q3 2025 Update",
    "summary": "Kenneth Fisherâs Q3 2025 portfolio update: NVDA leads, Apple and Microsoft expanded. See top stock picks and portfolio shifts. Read here for more insights.",
    "url": "https://finnhub.io/api/news?id=82565079d0e3e585ecae94be31e30982bd73627cd306f952901e881b97c65e2f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763066694,
      "headline": "Tracking Ken Fisher's Fisher Asset Management Portfolio - Q3 2025 Update",
      "id": 137475053,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/186805810/image_186805810.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Kenneth Fisherâs Q3 2025 portfolio update: NVDA leads, Apple and Microsoft expanded. See top stock picks and portfolio shifts. Read here for more insights.",
      "url": "https://finnhub.io/api/news?id=82565079d0e3e585ecae94be31e30982bd73627cd306f952901e881b97c65e2f"
    }
  },
  {
    "ts": null,
    "headline": "BMY's Growth Portfolio Shines in Q3: Turning Point Ahead?",
    "summary": "Bristol Myers' strong Q3 growth portfolio, led by Opdivo and Reblozyl, helped counter declines in legacy drug sales.",
    "url": "https://finnhub.io/api/news?id=29bda3e91c05f1eff9543fd18991f8fc0bea52076ad8d57b4e18e77cb1c103fb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763059500,
      "headline": "BMY's Growth Portfolio Shines in Q3: Turning Point Ahead?",
      "id": 137473211,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Bristol Myers' strong Q3 growth portfolio, led by Opdivo and Reblozyl, helped counter declines in legacy drug sales.",
      "url": "https://finnhub.io/api/news?id=29bda3e91c05f1eff9543fd18991f8fc0bea52076ad8d57b4e18e77cb1c103fb"
    }
  },
  {
    "ts": null,
    "headline": "Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls",
    "summary": "Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls",
    "url": "https://finnhub.io/api/news?id=5aafec13e5283a7c16cdd2ef7a281b860ab6773670749212b5df63a2284578b0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763045138,
      "headline": "Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls",
      "id": 137468541,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls",
      "url": "https://finnhub.io/api/news?id=5aafec13e5283a7c16cdd2ef7a281b860ab6773670749212b5df63a2284578b0"
    }
  },
  {
    "ts": null,
    "headline": "Merck to Participate in the Jefferies Global Healthcare Conference in London",
    "summary": "RAHWAY, N.J., November 13, 2025--Merck to Participate in the Jefferies Global Healthcare Conference in London",
    "url": "https://finnhub.io/api/news?id=37e9080f2bc104b307baeb378df06515a79a7f3b198f0c85f1133c87a6f83c7f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763034300,
      "headline": "Merck to Participate in the Jefferies Global Healthcare Conference in London",
      "id": 137466938,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "RAHWAY, N.J., November 13, 2025--Merck to Participate in the Jefferies Global Healthcare Conference in London",
      "url": "https://finnhub.io/api/news?id=37e9080f2bc104b307baeb378df06515a79a7f3b198f0c85f1133c87a6f83c7f"
    }
  },
  {
    "ts": null,
    "headline": "Should You Forget Pfizer and Buy This Magnificent Drug Stock Instead?",
    "summary": "Pfizer has a huge dividend yield and a high payout ratio compared to Merck, which could make Merck the more attractive dividend stock.",
    "url": "https://finnhub.io/api/news?id=56d63bb313d83eab53c6ea4d365b364b36030660921a8790422a648f1bfd874f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763027700,
      "headline": "Should You Forget Pfizer and Buy This Magnificent Drug Stock Instead?",
      "id": 137466939,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Pfizer has a huge dividend yield and a high payout ratio compared to Merck, which could make Merck the more attractive dividend stock.",
      "url": "https://finnhub.io/api/news?id=56d63bb313d83eab53c6ea4d365b364b36030660921a8790422a648f1bfd874f"
    }
  },
  {
    "ts": null,
    "headline": "1 Incredible Reason to Buy LLY's Stock in November",
    "summary": "Eli Lilly struck a deal with President Donald Trump last week that could send the stock much higher.",
    "url": "https://finnhub.io/api/news?id=0dda0ab3177e6218d231d3079e9a5283fcc1bc14b836d4ee830dc22d91682775",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763025900,
      "headline": "1 Incredible Reason to Buy LLY's Stock in November",
      "id": 137466726,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Eli Lilly struck a deal with President Donald Trump last week that could send the stock much higher.",
      "url": "https://finnhub.io/api/news?id=0dda0ab3177e6218d231d3079e9a5283fcc1bc14b836d4ee830dc22d91682775"
    }
  }
]